New hope for Tough-to-Treat personality disorder
NCT ID NCT05356013
Summary
This study tested whether the medication Caplyta could help reduce symptoms of borderline personality disorder (BPD). Sixty adults with BPD took either Caplyta or a placebo pill daily for eight weeks while continuing their regular therapy. Researchers measured whether those taking Caplyta showed greater improvement in emotional regulation, impulsivity, and other BPD symptoms compared to those taking placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.